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Antigen presentation by dendritic cells in renal lymph nodes is
linked to systemic and local injury to the kidney
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Antigen presentation by dendritic cells in renal lymph nodes is
linked to systemic and local injury to the kidney.
Background. Dendritic cells (DCs) uniquely serve as con-
duits between innate and cognate arms of the immune system.
The normal kidney contains an extensive population of intersti-
tial DCs but their role in the pathogenesis of acute renal injury
is not known.
Methods. Renal DCs were studied by flow cytometric analysis
of collagenase-digested mouse kidneys, by immunohistochem-
istry, and by immunofluorescence microscopy. In vivo ingestion
by DCs of intravenously administered fluorescein isothio-
cyanate (FITC)-dextran particles was examined. A model anti-
gen system (presentation of ovalbumin-derived peptide to TCR
transgenic CD4+ T-cells) was employed to examine the in-
fluence of systemic (lipopolysacchride injection) and localized
(unilateral renal artery clipping) renal injury on DC-mediated
T-cell activation in the renal lymph nodes (RLNs).
Results. Renal DCs were shown to constitute the predom-
inant source of T-cell stimulatory capacity within the kidney,
and to avidly ingest both filtered and nonfiltered particles.
Lipopolysaccharide resulted in disappearance of DCs from the
renal interstitium within 48 hours. This was accompanied by in-
creased renal lymph node DCs, some of which contained intra-
cellular Tamm-Horsfall Protein, indicating abnormal trafficking
of kidney-specific antigens following renal injury. Lipopolysac-
charide enhanced DC-mediated proliferation of ovalbumin-
specific CD4+ve T-cells within the draining RLN. Unilateral
renal ischemia augmented the capacity for DC-mediated T-cell
activation in the lymph nodes draining both the ischemic and
nonischemic kidney.
Conclusion. Renal DCs respond to systemic or localized
acute renal injury by increasing the traffic of protein antigens
from kidney to RLN, resulting in a concomitant increased po-
tential for localized activation of antigen-specific CD4+ve T-
cells.
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Dendritic cells (DCs) are bone marrow–derived,
antigen-presenting cells (APCs) with unique capacity to
activate naı¨ve T-cells [1, 2]. A wealth of research has
established the importance of DCs for normal and ab-
normal immune function [1, 3, 4]. Central to DC biol-
ogy is the phenotypic shift (“maturation”) that regulates
antigen-presenting potency [1, 3, 4]. In the immature
state, DCs exhibit high phagocytic capacity, relatively low
surface levels of class II major histocompatibility complex
(MHC II) and costimulatory proteins, and weak ability to
stimulate T-cell proliferation. Following maturation, DCs
switch to low antigen-uptake capacity, high surface levels
of MHC II and costimulatory ligands, and potent T-cell
stimulatory ability [1, 3, 4]. The signals that drive DC mat-
uration and, consequently, initiate antigen-specific T-cell
responses, derive from products of tissue injury (micro-
bial components, innate proinflammatory secretions) [1,
3–6]. In the absence of maturational stimuli, DCs play an
ongoing, active role in maintaining peripheral immune
tolerance through the induction of regulatory T-cells [7–
9]. Thus, DCs serve as unique conduits for cross-talk be-
tween innate and cognate arms of the immune system
and, through their varying interactions with T-cells, con-
tribute actively to both tolerance and immunity.
The presence of DCs within the renal parenchyma has
been established for both rodents and humans and, in
the healthy kidney, these cells form a readily demon-
strable population, expressing major histocompatibility
complex (MHC) and costimulatory proteins [10–15]. The
primary localization of renal DCs (rDCs) is within the
peritubular interstitium, where they are in close contact
with the basolateral surfaces of tubular epithelium and
peritubular capillaries [13–15]. Renal DCs are thus posi-
tioned to sense and respond to substances diffusing from
tubules to capillaries and are, therefore, likely to be di-
rectly influenced by alterations to the glomerular filtrate,
as well as to other changes in the interstitial compartment.
The recent expansion of knowledge regarding DC biol-
ogy suggests that rDCs merit closer study as potentially
important participants in forms of renal injury for which
there is evidence of maladaptive communication between
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innate and cognate arms of the immune system [16–21].
It is well established from animal and human studies that
influx of inflammatory cells to the renal parenchyma char-
acteristically occurs during acute renal failure associated
with sepsis/endotoxinemia and in the wake of localized
insults such as ischemia-reperfusion and ureteral obstruc-
tion [22, 23]. In elucidating the impact of intraparenchy-
mal inflammation on the extent of experimental renal
injury, much emphasis has been placed on the effector
role of cell populations such as macrophages and neu-
trophils, which constitute components of the innate im-
mune response. It is evident from experiments involving
depletion of macrophages or inhibition of macrophage
recruitment that this lineage contributes to the decline in
renal function that follows a period of ischemia. More re-
cently, however, T lymphocytes (T-cells) have also been
identified as having a direct pathogenic role in the cau-
sation of acute renal failure in the context of generalized
ischemia [24], as well as localized ischemia-reperfusion of
the kidney [25]. Although the antigen specificity of T-cells
involved in acute renal injuries remains to be determined,
it is implicit from these observations that new or modi-
fied interactions between T-cells and antigen-presenting
cells (APCs) occur following ischemia-reperfusion, and
that these antigen presentation events are potentially in-
jurious to the kidney. In further support of this concept,
blockade of the CD80/CD86 costimulatory ligands atten-
uates ischemia-reperfusion injury [17, 19].
We hypothesized that the T-cell activation and sub-
sequent T-cell–mediated injury associated with specific
renal insults is induced by alterations to the kinetic
and phenotypic characteristics of rDCs. Specifically, we
postulated that whole body or localized proinflamma-
tory events initiate early efflux of DCs from the renal
parenchyma to the draining lymphoid tissue, leading to
abnormal DC-mediated trafficking of antigens derived
from the kidney and antigen-specific T-cell activation
within renal lymph nodes (RLNs). In support of this the-
sis, and in a murine model system, we demonstrate (1) the
predominant antigen uptake and presentation capacity of
DCs within the kidney parenchyma, and (2) the poten-
tial for rDCs to mediate abnormal antigen transfer and
antigen-specific T-cell activation within RLNs following
renal injury.
METHODS
Experimental animals and reagents
C57BL/6, BALB/C (Jackson Laboratories, Bar
Harbor, ME, USA) and DO11.10 mice were main-
tained in a specific pathogen-free facility. Tissue
culture was carried out in Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 10% fetal calf
serum (FCS) (Invitrogen Corp., Carlsbad, CA, USA).
Mouse-specific detection reagents used were: fluo-
rescein isothiocyanate (FITC)-, phycoerythrin (PE)-,
and biotin-coupled anti-CD11c (clone HL3), anti-I-
Ab-biotin (AF6-120.1), anti-H-2Db-biotin (28–14-8),
anti-H-2Kb-biotin (AF6-88.5), anti-CD86-PE (GL1),
anti-CD80-PE (16-10A1), anti-CD40-PE (3/23), anti-
ICAM-1-PE (3E2), anti-ICAM-2-biotin (3C4-mlC2/4),
anti-CD8a-PE (53–6.7), anti-CD4-CyChrome (RM4.4),
streptavidin-PerCP (BD Pharmingen, San Diego, CA,
USA); sheep anti-Tamm-Horsfall Glycoprotein (THP)
(BioTrend Chemikalien GmbH, Cologne, Germany);
Alexa Fluor 594-conjugated streptavidin, Alexa Fluor
488-coupled donkey antisheep IgG (Molecular Probes,
Eugene, OR, USA); biotin coupled anti-DO11.10 TCR
(KJ1-26, kindly provided by Dr. Larry Pease, Dept. of
Immunology, Mayo Clinic, Rochester, MN, USA).
Collagenase/DNase disruption of mouse organs
Kidneys and lymphoid organs were cut into 1 to
2 mm3 pieces, placed in DMEM containing 1.6 mg/mL
collagenase I (Sigma Aldrich, St. Louis, MO, USA),
and 200 lg/mL DNase I (Roche Applied Science, Indi-
anapolis, IN, USA) for 40 minutes at 37◦C with inter-
mittent agitation, washed, resuspended in DMEM/200
lg/mL DNase I at room temperature for 15 minutes, and
washed twice in DMEM. Following erythrocyte lysis, cells
were resuspended in DMEM/10% FCS or FACs buffer
(PBS/0.2%BSA/0.02%NaN2). Kidney cell suspensions
were allowed to settle for 20 minutes, following which
the upper two thirds (lower density cells) was removed
for subsequent assays. For flow cytometry, aliquots of 0.25
to 4.0 × 105 cells were incubated in FACs buffer at 4◦C,
with fluorochrome-labeled and/or biotinylated antibod-
ies followed by fluorochrome-labeled streptavidin. Sam-
ples were analyzed using a FACscanTM flow cytometer
and CellquestTM software (BD Pharmingen, San Diego,
CA, USA).
Magnetic bead enrichment of CD11c+ve cells and
coculture with CFSE-labeled allogeneic T-cells
Cells prepared from collagenase/DNase-digested
BALB/C kidneys and lymphoid organs were suspended
in MACS buffer (PBS, 0.5% BSA, 2 mmol/L EDTA) at
90 lL/107 cells; incubated with anti-CD11c–coated mi-
crobeads (10 lL/107 cells; Miltenyi Biotech, Inc., Auburn,
CA, USA) at 4◦C for 20 minutes; washed and resus-
pended in 1 mL MACS buffer. Positive and negative
fractions were separated using the miniMACSTM sepa-
ration system (Miltenyi Biotech), then washed and re-
suspended in DMEM/10% FCS. For mixed lymphocyte
reactions, purified T-cells were prepared from spleens and
lymph nodes of adult C57BL/6 mice by similar magnetic
column separation following incubation with anti-Thy1.2
microbeads, then were labeled with CFSE. The CFSE-
labeled T-cells were plated in 96-well round-bottom tissue
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culture plates at 2 × 105 cells per well. CD11c-enriched
and CD11c-depleted cell populations from BALB/C kid-
ney and were added at 2 × 104 cells per well. As a positive
control, CD11c-enriched cells from spleen were added
at the same ratio to additional wells. All experimental
conditions were carried out in triplicate. Following 72
hours of coculture, cells from individual wells were lifted,
stained with anti-CD4-PE or anti-CD8-PE, and analyzed
by 3-color flow cytometry. Proliferation of C57BL/6 T-cell
subsets for each condition was expressed as mean ± SD
percent divided on the basis of CFSE dilution of CD4+ve
or CD8+ve cells.
Administration of FITC-dextran particles
FITC-Dextran of Mr 40,000, and 500,000 (Sigma
Aldrich) were suspended in phosphate-buffered saline
(PBS) and injected intravenously into groups of 3
C57BL/6 mice at 5 mg/animal. A control group received
PBS. One hour later, the spleens and kidneys were di-
gested with collagenase/DNase I, cell suspensions were
stained with DC-specific antibody (anti-CD11c-PE), and
analyzed by 2-color flow cytometry. Uptake of fluores-
cent particles by DCs and non-DCs cells within individ-
ual samples was expressed quantitatively as mean fluores-
cence intensity (MFI) on the FL-1 channel of CD11c+ve
and CD11c−ve cell populations. Results for each experi-
mental group were expressed as mean ± SD of the MFI.
Immunoperoxidase and immunofluorescence
microscopy
C57BL/6 mice were injected intravenously with 50 lg
lipopolysaccharide (LPS) in PBS or with PBS alone. At
varying time-points later, kidneys, renal lymph nodes,
spleens, and subcutaneous lymph nodes were removed,
placed in embedding medium (OCT compound), and
frozen in liquid nitrogen–cooled isopentene. For im-
munoperoxidase staining, 6 lm cryosections on silane-
coated slides were fixed in acetone (−20◦C for 10 min),
air-dried, and rinsed in PBS. Endogenous peroxidase ac-
tivity was blocked with 0.3% H2O2 in PBS for 10 min-
utes (lymphoid sections) or 50 minutes (kidney sections),
and slides were rinsed in PBS. Normal goat serum (5%
in PBS) was applied for 1 hour, followed by blockade
of endogenous biotin (Vector Laboratories, Burlingame,
CA, USA) and sequential incubations with sheep anti-
THP antibody followed by biotinylated antisheep anti-
body for 1 hour each in a humidified chamber. Slides
were rinsed in PBS, incubated with ABC complex (Vec-
tor Laboratories) for 45 minutes, rinsed again, and DAB
(brown) substrate solution was applied and allowed to
develop to the desired color intensity. For 2-color im-
munoperoxidase staining, a second round of incubations
with biotinylated anti-CD11c, ABC complex, and VIP
(purple) substrate (Vector Laboratories) was carried out.
Finally, the slides were rinsed in tap water, counterstained
with hematoxylin, rinsed again in tap water, dehydrated
through 4 changes of alcohol (80%, 95%, 100%, and
100%), cleared in 3 changes of xylene and mounted with
CytosealTM 60 (Richard-Allan Scientific, Kalamazoo, MI,
USA). For immunofluorescent staining, acetone-fixed
sections were blocked for 1 hour with 5% normal don-
key serum in PBS, followed by endogenous biotin block-
ade and incubation with sheep anti-THP and biotinylated
anti-CD11c antibodies for 1 hour. After rinsing in PBS,
slides were incubated with Alexa Fluor 488-conjugated
antisheep antibody and Alexa Fluor 594-Streptavidin
(1:500) for 45 minutes, then rinsed again, mounted using
VECTASHIELD mounting medium with DAPI (Vec-
tor Laboratories) and examined under confocal laser-
scanning microscopy (LSM510; Carl Zeiss, Go¨ttingen,
Germany).
In vivo stimulation of adoptively transferred,
CFSE-labeled DO11.10 cells
Erythrocyte-depleted cell suspensions were prepared
from spleens and lymph nodes of adult DO11.10 as previ-
ously described [46], incubated with antimouse-CD4 mi-
crobeads (10 lL/107 cells, Miltenyi Biotech) at 4◦C for 20
minutes, washed and resuspended in 1 mL MACS buffer,
then separated into positive and negative fractions us-
ing the miniMACSTM system. The CD4+ve fraction was
washed in PBS, labeled with CFSE, resuspended in PBS,
then injected intravenously into gender-matched, adult
BALB/C recipients at 2.5 to 3.5 × 106 cells per animal.
Between 48 and 96 hours after adoptive transfer, recipient
mice were anesthetized, a 1 cm incision was made in the
left flank, the left kidney was briefly externalized, and 50
lL of ovalbumin solution (1 mg/mL in PBS) was injected
beneath the capsule with a 1 mL syringe and 27-gauge
needle. The flank incision was closed in a single layer us-
ing 5-O prolene suture, and animals were observed for 2
hours, after which groups were injected intraperitoneally
with LPS (50 lg in PBS) or with PBS alone. Three days
later, the groups of mice were sacrificed and analysis of
DO11.10 T-cell division within spleens and lymph nodes
was carried out by 3-color flow cytometric analysis of cell
suspensions stained with anti-Thy1.2-PE and biotinylated
KJ1-26 (anti-DO11.10 TCR) followed by streptavidin-
PerCP. Expansion of DO11.10 T-cells was determined by
comparing the mean ± SD for the proportion of KJ1-
26+ve cells within the total Thy1.2+ve cells among individ-
ual groups of samples. Degree of DO11.10 T-cell division
was determined by comparing the mean ± SD for the
proportion of Thy1.2+ve/KJ1-26+ve cells that had passed
through 5 or more cell divisions among individual groups
of samples.
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Unilateral renal artery clipping in mice
Unilateral renal ischemia was imposed in adult
BALB/C mice under pentobarbitol anesthesia by total
occlusion of the left renal artery as described [47]. The
procedure was performed on a heated surface to ensure
maintenance of normal body temperature. The kidneys
were exposed via a midline abdominal excision; the left
renal pedicle was carefully dissected, then clamped for
22.5 minutes using a nontraumatic sterile clamp (RS5426,
Microaneuryam clip, straight 10 mm, 125-g pressure;
Roboz Surgical Instrument, Rockville, MD, USA). For
each experiment, a group of animals underwent a sham
procedure including anesthesia and laparotomy but omit-
ting clamping of the renal pedicle. Immediately after
placement of the clip, ovalbumin (100 lL of a 2 mg/mL
solution in PBS) was injected beneath the left renal cap-
sule using a 27-gauge needle. The abdominal incision was
closed in separate layers using 5–0 prolene sutures. Ani-
mals were observed for 2 hours after the procedure and
sacrificed 24 hours later for preparation of cell suspension
from lymphoid organs.
In vitro stimulation of CFSE-labeled DO11.10 T-cells
Stimulators. Cell suspensions were prepared by
collagenase/DNase-digestion of pooled left RLNs, right
RLNs, and SLNs from groups of experimental animals.
A portion of each sample was retained for use as the
“unsorted” stimulator fraction, and the remainder was la-
beled with anti-CD11c microbeads and subjected to mag-
netic column separation as described above. The resulting
positive and negative fractions were retained as “CD11c-
enriched” and “CD11c-depleted” stimulator fractions.
Responders. Purified CFSE-labeled DO11.10 T-cells
were prepared as described above and plated in 96-well,
round-bottom tissue culture plates at 1 or 2 × 105 cells
per well. Stimulator cell populations were added at 5 ×
104 (unsorted and CD11c-depleted) or 1 × 104 (CD11c-
enriched) cells per well. Between 3 and 6 replicates of
each experimental condition were initiated. Following
96 hours of coculture, cells from individual wells were
lifted, stained with anti-CD4-PE and biotinylated KJ1-26
biotin followed by streptavidin-PerCP, and analyzed by 3-
color flow cytometry. Proliferation of DO11.10 T-cells for
each condition was expressed as mean ± SD percent di-
vided on the basis of CFSE dilution of CD4+ve/KJ1-26+ve
cells.
Statistical analysis
For experiments comparing flow cytometric analysis of
DCs from different organs, the mean fluorescence inten-
sity (MFI) of DC-surface staining for a given organ was
expressed as mean ± SD of the measured values for each
animal. For assays of in vivo and in vitro lymphocyte ex-
pansion, each condition results were expressed as mean ±
SD, and individual conditions were compared statistically
using unpaired, two-sided Student t test with significance
assigned to P < 0.05.
RESULTS
Dendritic cells are the predominant resident population
of antigen-presenting cells in the healthy kidney
The phenotype and antigen presenting capacity of DCs
from the healthy mouse kidney were initially character-
ized by employing a collagenase/DNase digestion proto-
col to prepare cell suspensions for flow cytometry and
magnetic column purification, using CD11c as the pri-
mary distinguishing marker. Flow cytometric analysis of
samples from multiple animals demonstrated that surface
levels of MHC II (I-A) and MHC I (H-2D, H-2K), as
well as of the costimulatory proteins CD80 (B7-1), CD86
(B7-2), CD40, and ICAM-1 were significantly lower on
renal DCs (rDCs) than on DCs from subcutaneous lymph
nodes, spleen, thymus, and renal lymph nodes (data not
shown). In contrast to the lymphoid organs, there were
no CD8+ve DCs within the kidney (data not shown). The
results of this initial phenotypic characterization confirm
the recent findings of Kruger [26].
To confirm that DCs constitute the major APC popula-
tion in the healthy kidney, CD11c-enriched (CD11c+ve)
and -depleted (CD11c−ve) cell fractions were prepared
from collagenase/DNase-digested kidneys and were co-
cultured with purified allogeneic T-cells labeled with the
fluorescent dye CFSE (Fig. 1). Counterstaining with ap-
propriate PE-labeled antibodies was used to separately
determine proliferation of MHC 1- (CD8+ve) and MHC
II-restricted (CD4+ve) T-cells. Cocultures of T-cells with
CD11c+ve and CD11c−ve populations from spleen were
also carried out. As shown, the CD11c+ve cells from kid-
ney induced proliferation of both CD4+ve and CD8+ve
T-cells, while the CD11c−ve cells induced only minimal
CD8+ve T-cell proliferation. Splenic CD11c+ve cells were
more potent T-cell stimulators than those from the kid-
ney. Thus, DCs from the kidney exhibit a relatively
immature phenotype, are exclusively of the “myeloid”
(CD8−ve) subgroup, and constitute the predominant res-
ident APC population in the healthy adult kidney.
Renal DCs phagocytoze filtered and unfiltered particles
from the circulation
The ability of renal and splenic DCs to ingest material
present in the circulation was examined by intravenous
administration of FITC-dextran particles to healthy mice.
To determine whether rDCs are preferentially exposed to
materials that pass through the glomerular filtration bar-
rier, uptake of FITC-dextran particles of approximate Mr
40,000 (filtered) or 500,000 (not filtered) were separately
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Fig. 1. Analysis of the T-cell stimulatory capacity of CD11c-depleted and CD11c-enriched cell populations from the kidney and comparison with
splenic CD11c-enriched cells. Cell suspensions from kidney were separated into CD11c-depleted (CD11c−ve) and CD11c-enriched (CD11c+ve)
fractions using anti-CD11c-coated microbeads and magnetic separation. (A) Restaining of the separated cells for MHC II (I-Ab) and CD11c
demonstrated clear enrichment for double-positive cells in the CD11c+ve (74%) compared with CD11c−ve (4%) fractions. (B) Coculture of
CD11c+ve and CD11c−ve kidney cells as well as CD11c+ve splenic cells with CFSE-labeled fully allogeneic T-cells for 72 hours followed by flow
cytometric analysis to separately detect cell division (reduced CFSE fluorescence) among the CD4+ve and CD8+ve T-cells (left panel). Cell division
was quantified as the proportion of the total CD4+ve or CD8+ve cells that had undergone cell division (% divided) and was expressed graphically
as mean ± SD for triplicate samples of each coculture condition (right panel). †P < 0.05 compared to T cells alone; ‡P < 0.05 compared to renal
CD11c−ve.
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examined. Flow cytometric analysis of individual spleen
and kidney cell suspensions was carried out 1 hour after
injection of PBS alone, FITC-dextran 40,000, or FITC-
dextran 500,000 with gating on CD11c+ve cells (Fig. 2).
Uptake of FITC-dextran by DCs and other cell popu-
lations could be readily detected by increased relative
fluorescence (Fig. 2A). When expressed quantitatively
(Fig. 2B), the results demonstrated ingestion of both fil-
tered and unfiltered particles by rDCs. The fluorescence
shift of rDCs was higher than that of splenic DCs for
both FITC-dextran preparations, suggesting a relatively
greater phagocytic capacity.
A systemic proinflammatory stimulus results
in migration of DCs from the renal interstitium to
draining lymph nodes and in DC-mediated transfer
of a kidney-specific protein
Dendritic cells were visualized in situ by immunohis-
tochemical staining of mouse kidneys and renal lymph
nodes (RLNs) at different time points following intra-
venous administration of LPS (Fig. 3). Interstitial MHC
II+ve cells, morphologically consistent with DCs, were
readily detected within the renal cortex at baseline and
at 4 hours after LPS injection. At 24 hours, MHC II+ve
cells were substantially reduced in number. By 48 hours,
the interstitium was essentially devoid of DCs. In RLNs at
baseline and 4 hours, CD11c+ve cells were present at mod-
erate density in the medullary (T-cell) zone. At 24 hours
and 48 hours, there was an increase in CD11c+ve cells such
that confluent staining of the RLN medulla was observed.
Identical results were obtained from 5 animals.
The latter results suggested the potential for a sys-
temic inflammatory stimulus to alter the trafficking of
endogenous antigens from the kidney to the T-cell com-
partment of draining lymphoid tissue. In order to for-
mally test this hypothesis, RLNs, removed 48 hours after
treatment with PBS or LPS, were double-stained by im-
munoperoxidase for CD11c and for the kidney-restricted
glycoprotein THP [28]. Rare cells with positive immunos-
taining for both CD11c and THP were detected within
multiple renal lymph node sections from LPS-treated but
not PBS-treated animals (Fig. 4A). In separate experi-
ments, immunofluorescence staining for CD11c and THP
was employed to definitively localize THP+ve material to
the cytoplasmic region of CD11c+ve cells in the RLNs at
48 hours and 7 days post-LPS injection (Fig. 4B). Indi-
vidual CD11c+ve cells were detected at 48 hours contain-
ing discrete intracytoplasmic bodies that were strongly
positive for THP. A total of 20 such cells were detected
within 497 sections of RLNs from 9 LPS-treated animals.
No CD11c+ve/THP+ve cells were detected in RLNs of
PBS-treated animals or in nonrenal lymph nodes of LPS-
treated animals. Seven days after LPS injection, THP-
containing DCs could still be detected in RLNs, indicat-
ing an ongoing trafficking process.
Dendritic cell-mediated proliferation of antigen-specific
T-cells in the renal lymph nodes is augmented by
a systemic proinflammatory stimulus
An in vivo model system was derived to examine RLN
T-cell activation in response to protein antigen localized
to the kidney. Ovalbumin (OVA) solution was introduced
beneath the left kidney capsule of mice containing CFSE-
labeled, adoptively transferred TCR transgenic CD4+ve
T-cells with specificity for a MHC II-restricted OVA-
derived peptide (DO11.10 T-cells). Shortly after OVA
introduction, groups of mice received either PBS or LPS
solution intravenously. Three days later, relative expan-
sion and cell division profiles of DO11.10 T-cells were
examined by flow cytometry in the left and right RLNs,
mesenteric lymph nodes (MLNs), subcutaneous lymph
nodes (SLNs), and spleens of the two groups (Fig. 5).
The results demonstrated that, for both control and LPS-
treated animals, a localized expansion of DO11.10 T-cells
occurred in the left renal node. Analysis of cell division
profiles (based on CFSE dilution of DO11.10 T-cells at
each site) further demonstrated that LPS-treated animals
exhibited accelerated progression of T-cell proliferation
in the left RLN (as reflected in a significantly higher pro-
portion of the cells that had undergone more than 5 cell
divisions at the time of analysis). It was also evident that
some DO11.10 T-cell proliferation occurred in the right
RLN as well as at other lymphoid sites, likely due to
low-level dissemination of OVA itself or of left kidney–
derived DCs. LPS-associated acceleration of DO11.10 T-
cell proliferation occurred within the right RLN and, to
a lesser degree, within SLNs, but not within MLNs or
spleen.
The predominant role of DCs in processing and pre-
senting OVA-derived peptides in this model system was
confirmed by examining the ability of unsorted, CD11c-
depleted, and CD11c-enriched cell populations to induce
in vitro proliferation of resting DO11.10 T-cells 24 hours
after introduction of OVA beneath the left kidney
capsule (Fig. 6). Cell populations from left RLNs, right
RLNs, and SLNs were cocultured with CFSE-labeled
DO11.10 T-cells for 72 hours, after which cell division was
examined by flow cytometry. As shown, unsorted and
CD11c-enriched cells from the left RLN of PBS-treated
mice stimulated DO11.10 T-cell proliferation, while the
CD11c-depleted fraction did not (Fig. 6A). The relative
potency of the CD11c-enriched fraction is highlighted by
the fact that the number of stimulator cells used for this
fraction was reduced to 20% of that used for unsorted
and CD11c-depleted populations. For PBS-treated
animals, T-cell stimulatory capacity was absent in all cell
fractions from right RLN and SLNs. In a group of animals
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Fig. 2. Uptake of FITC-dextran particles by renal and splenic DCs. Cell suspensions were prepared from kidneys and spleens of groups of 3
healthy adult mice 1 hour after administration of PBS (“Control”), FITC-dextran particles that pass through the glomerular filtration barrier and
into the urinary space (FITC-dextran Mr 40,000), and FITC-dextran particles that are precluded from the urinary space (FITC-dextran Mr 500,000).
Following surface staining with anti-CD11c-PE, flow cytometry was carried out to examine uptake of FITC by DCs (CD11c+ve cells) and all other
cells (total cells). Examples of dot-plots for spleen and kidney from each group are shown (upper panel, DCs are indicated by boxes). Graphic
representation of the results is also shown (lower panel). The presence of fluorescent material within total and CD11c+ve cell populations was
expressed quantitatively for each cell population as mean ± SD of the mean fluorescence intensity (MFI) on the FL-1 channel. †P < 0.05 compared
with control group, ‡P < 0.05 for kidney compared with spleen cells.
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Fig. 4. Detection of DCs containing Tamm-
Horsfall protein (THP) in renal lymph nodes
following intravenous injection of LPS. (A)
Left panel: Immunoperoxidase staining of
normal adult mouse kidney for THP demon-
strated the expected restriction of staining to
distal tubular epithelium. Right panel: Exam-
ples of 2-color immunohistochemical stain-
ing of sections of renal lymph nodes from
adult mice that had received LPS 48 hours
previously. Sections were double-stained for
CD11c (mauve) and THP (brown). Individ-
ual cells that clearly stained positive for both
CD11c and THP are shown. (B) Examples of
immunofluorescent staining for CD11c (red)
and THP (green) of renal lymph node sec-
tions from adult mice that had received LPS
48 hours (left two panels) or 7 days (right
panel) previously. Nuclei are indicated by
DAPI (blue) staining. Individual CD11c+ve
cells contained THP-positive intracytoplas-
mic bodies are shown.
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 3. Immunoperoxidase staining for DCs in kidney and renal lymph
nodes of mice at various time-points following intravenous injection of
LPS. Examples are shown of immunoperoxidase staining for DCs in
the kidney (anti-MHC II) and renal lymph nodes (anti-CD11c) of mice
before (“0,” panels A and B), and 4, 24, or 48 hours after intravenous
injection of LPS (panels C to H). For both organs, DCs are identified
at 0 and 4 hours by strong staining of individual cells (high-power views
of single cells shown in inserts to A and B). At 24 and 48 hours, a
large increase of DCs numbers within renal lymph nodes is indicated
by virtually confluent staining of the central (medullary) zone (panels F
and H). At these same time-points, MHC II–positive cells in the kidney
interstitium are greatly reduced in frequency (24 hours, panel E) or
absent (48 hours, panel G).
treated with LPS shortly after OVA introduction
(Fig. 6B), DO11.10 T-cell proliferation was induced by
CD11c-enriched fractions from right RLNs and SLNs
also, again suggesting an effect of the systemic proin-
flammatory stimulus to cause dissemination of antigen or
antigen-containing DCs beyond the site of local antigen
uptake.
Renal ischemia is associated with augmented
antigen-specific T-cell activation that is localized
to the renal lymph nodes and mediated by DCs
The influence of renal ischemia on DC-mediated
antigen-specific T-cell activation within RLNs was next
determined. Groups of mice were subjected to unilat-
eral (left) renal ischemia-reperfusion (IR) or to sham
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Fig. 5. Proliferation of antigen-specific T-
cells in the renal lymph nodes following
subcapsular inoculation of ovalbumin and
augmentation by systemic administration of
LPS. (A) Examples of flow cytometric anal-
ysis of adoptively transferred, CFSE-labeled
DO11.10 T-cells from left and right renal
lymph nodes (L.N.) and mesenteric L.N. of
mice at 72 hours’ post-inoculation of ovalbu-
min beneath the left renal capsule followed by
subsequent intraperitoneal injection of PBS
(upper dot plots) or LPS (lower dot plots).
Dot plots are gated on Thy1.2+ve cells and
demonstrate CFSE dilution of DO11.10 (KJ1-
26+ve) T-cells. Adoptively transferred T-cells
that had undergone 6 or more cell divisions
are indicated in boxes (left renal L.N. samples
only). (B) Relative expansion of adoptively
transferred DO11.10 T-cells within individual
left and right renal, mesenteric, and subcu-
taneous L.N.s and spleens of PBS and LPS-
treated mice at 72 hours’ post-inoculation of
ovalbumin beneath the left renal capsule. Re-
sults are expressed as mean ± SD of the
proportion of total T-cells (Thy1.2+ve) that
were also positive for the DO11.10 TCR
(KJ1-26+ve). (C) The proportion of adop-
tively transferred DO11.10 (Thy1.2+ve/KJ1-
26+ve) T-cells that had undergone more than
5 cell divisions is shown graphically for each
lymphoid organ from PBS- and LPS-treated
mice. †P < 0.05 for left RLN compared with
right RLN, MLN, SLN, and spleen; ‡P < 0.05
for LPS group compared with PBS group.
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Fig. 6. Presentation of ovalbumin-derived peptide by renal lymph
node cells following subcapsular inoculation of ovalbumin is restricted
to the CD11c+ve (DC) fraction. In vitro proliferation of CFSE-labeled
DO11.10 T-cells is shown graphically following 96 hour coculture with
unsorted, CD11c-depleted, and CD11c-enriched stimulator popula-
tions derived from the pooled left and right renal and subcutaneous
lymph nodes of groups of mice inoculated, 24 hours previously, with
ovalbumin beneath the left renal capsule. Results are shown for groups
additionally inoculated intraperitoneally with PBS (A) or LPS (B). For
each stimulator population, proliferation was expressed as mean ± SD
of the proportion of DO11.10 T-cells that had undergone cell division
(“% divided”—derived by flow cytometric analysis of replicate samples
for CFSE dilution of CD4+ve/KJ1-26+ve cells). †P < 0.05 compared to
CD11c-depleted; ‡P < 0.05 compared to right RLN and SLNs.
surgery (control). Ovalbumin was introduced beneath
the left renal capsule in both groups at the time of
surgery. Twenty-four hours later, the capacity of unsorted,
CD11c-enriched, and CD11c-depleted cell populations
from left RLNs, right RLNs, and SLNs to induce in
vitro proliferation of resting CFSE-labeled DO11.10 T-
cells was examined (Fig. 7). As for previous experiments,
stimulator cell numbers for CD11c-enriched fractions
were reduced to 20% of those for unsorted and CD11c-
depleted fractions. For both IR and control groups, un-
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Fig. 7. Renal ischemia-reperfusion augments the capacity for DC-
mediated stimulation of antigen-specific T-cells within draining and
contralateral renal lymph nodes. In vitro proliferation of CFSE-labeled
DO11.10 T-cells is shown graphically following 96 hour coculture with
unsorted, CD11c-depleted, and CD11c-enriched stimulator popula-
tions derived from the pooled left and right renal and subcutaneous
lymph nodes of groups of mice (N = 5) subjected, 24 hours previously,
to sham surgical procedure (A) or to left renal artery clipping for 22.5
minutes (B). For each stimulator population, proliferation is expressed
as mean ± SD of the proportion of DO11.10 T-cells that had undergone
cell division (“% divided”—derived by flow cytometric analysis of repli-
cate samples for CFSE dilution of CD4+ve/KJ1-26+ve cells). †P < 0.05
compared to CD11c-depleted; ‡P < 0.05 compared to unsorted; ¶P <
0.05 compared to corresponding sample from sham surgery group.
sorted and CD11c-enriched cells from the left RLNs as
well as CD11c-enriched cells from the right RLNs stim-
ulated DO11.10 T-cell proliferation. In both groups, the
CD11c-enriched fraction induced significantly greater T-
cell proliferation compared to unsorted cells, while the
CD11c-depleted fractions were devoid of T-cell stimu-
latory capacity (Fig. 7A and B). Comparison of results
for IR and control groups demonstrated that the CD11c-
enriched fraction from left RLNs of mice subjected to
IR induced higher levels of DO11.10 T-cell proliferation
than the corresponding fraction from the control group
(Fig. 7A and B). The CD11c-enriched fraction from the
right RLNs of the IR group was also associated with
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increased T-cell proliferation compared to the corre-
sponding control group fraction. Finally, for SLNs, a mod-
est increase in T-cell proliferation occurred following
coculture with CD11c-enriched cells compared with un-
sorted and CD11c-depleted fractions from the IR but
not the control group. Comparable findings were ob-
served in multiple similar experiments. The results were
interpreted as indicating that unilateral renal ischemia-
reperfusion is associated with: (1) increased capacity for
DC-mediated activation of antigen-specific T-cells within
lymph nodes draining the ischemic kidney; and (2) a con-
comitant increase in DC-mediated antigen presentation
within the contralateral, nonischemic kidney and, to a
lesser extent, within distant lymphoid tissue.
DISCUSSION
To the best of our knowledge, studies to date have not
explored the functional significance of DCs derived from
the kidney following localized ischemic insults or sys-
temic inflammation induced by LPS. As such, our present
analysis breaks new ground, providing novel insights into
the interplay between the immune system and acute re-
nal injury in general, and the involvement of DCs in such
interplay in particular. By focusing on DCs from the kid-
ney and its draining lymph nodes, we demonstrate that
this population of cells has a broad capacity to ingest ma-
terial in the renal vascular and interstitial compartments,
and is primarily responsible for presenting peptides de-
rived from renal proteins to antigen-specific CD4+ve
T-cells within RLNs. Furthermore, in vivo model sys-
tems confirm that, in the context of systemic and localized
proinflammatory states, DCs specifically mediate abnor-
mal transfer of renal proteins to the RLNs and enhance-
ment of T-cell proliferation.
Dendritic cells within the kidney were first character-
ized in the course of ultrastructural studies of the per-
itubular interstitium rather than by their immunologic
properties. Renal DCs were defined on the basis of MHC
II expression as well as the presence of multiple finger-
like processes abutting the tubular basement membrane
[13–15], and were shown to be abundant within the cortex
and outer medulla [11–15]. Based on this anatomic loca-
tion it might be speculated that rDCs primarily acquire
antigenic material from reabsorbed glomerular filtrate
or derived directly from tubular epithelial cells and in-
terstitial fibroblasts. Nevertheless, in the normal kidney,
we demonstrated equally efficient uptake by rDCs of fil-
tered and nonfiltered dextran particles. Thus, DCs within
the interstitial compartment of the kidney possesses the
capacity for uptake of endogenous as well as exogenous
antigens from all compartments of the normal kidney, and
for delivery of high loads of antigenic peptides to lympho-
cytes within draining lymphoid tissue. Counterbalancing
this high capacity for antigen presentation, DCs in the
healthy kidney are of relatively low maturity [26] and,
compared with DCs from lymphoid organs [27], undergo
low, steady state turnover (<20% over 2 weeks by in vivo
bromodeoxyuridine labeling—Matthew D. Griffin, un-
published observation). The capacity of a systemic proin-
flammatory stimulus to substantially accelerate the rate
of transit of DCs from the kidney to regional lymph nodes
was highlighted by a large increase in DC density within
the T-cell compartment of RLNs within 48 hours of LPS
injection, accompanied by virtual disappearance of DCs
from the renal parenchyma [12]. Taken together, these
observations confirm the potential for rDCs to broadly
and continuously sample the microenvironment of the
renal interstitium and to be directly influenced by proin-
flammatory stimuli.
Recent studies have revealed that DC-mediated traf-
ficking of endogenous antigens from individual organs
to draining lymph nodes represents an important mecha-
nism for maintenance of immune tolerance to peripheral
antigens [7, 29–33]. In these studies, DCs containing
tissue-specific proteins have been directly visualized
within afferent lymph or draining lymph nodes [29, 30].
Interestingly, Scheinecker et al have recently shown that
the frequency within gastric lymph nodes of DCs con-
taining a gastric epithelial antigen was greatly increased
during autoimmune gastritis [34]. Thus, alterations in cy-
cling of self-antigens to lymph tissue may represent a key
event in organ-specific autoimmunity. In this context, the
detection of DCs containing THP in RLNs shortly after
an inoculum of LPS indicates that altered trafficking of
kidney-specific proteins occurs as an early consequence
of renal injury. The fact that THP-positive DCs were not
detected in RLNs of control animals may indicate that,
in contrast to mucosal organs, trafficking of endogenous
proteins from the kidney does not occur during health.
Alternatively, it is possible that low-level trafficking from
the kidney occurs and is involved in maintenance of toler-
ance to kidney-restricted antigens. The latter possibility
is supported by the results of Kurts et al in transgenic
mice expressing ovalbumin in pancreatic islets and re-
nal proximal tubular epithelium [35, 36]. In this report,
adoptive transfer of ovalbumin-specific T-cells was asso-
ciated with proliferation of the T-cells specifically within
pancreatic and renal lymph nodes, indicating that anti-
gen from the kidney had been processed and presented
by an APC population (most likely DCs). Using a model
system in which ovalbumin was introduced beneath the
kidney capsule, we show here definitively, that produc-
tive, DC-mediated presentation of MHC II/peptide com-
plex to CD4+ve T-cells occurs in localized fashion in the
draining RLN. Because the experimental system necessi-
tated manipulation of the kidney, it cannot be concluded
that the degree of localized T-cell expansion observed
in non-LPS–treated animals represents the product
of steady state DC kinetics. Nonetheless, the observed
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effect of LPS to increase the rate of ovalbumin-specific T-
cell division, together with the previously demonstrated
increase in DC trafficking and antigen transfer, indicate
that DC-induced activation of CD4+ve T-cells in RLNs is
augmented in the context of acute sepsis/endotoxinemia.
Additional studies with transgenic model antigen systems
may further elucidate the role of rDC-mediated transfer
of endogenous renal antigens in the pathogenesis of acute
tubular injury.
T-cells mediate renal parenchymal injury in a variety of
disorders for which “foreign” antigenic stimuli (infectious
organisms, medications, toxins) are absent. Examples in-
clude ischemia-reperfusion (IR), partial nephrectomy,
and hereditary nephritis [16, 18, 20, 21, 23–25, 37–43].
Ischemia-reperfusion represents the most common cause
of acute renal failure and is associated with high mortality
in hospitalized patients. Many recent studies have demon-
strated the important role of mononuclear cells in the
pathogenesis of acute renal failure due to ischemic injury.
In experimental models of IR, monocyte/macrophages
and T-cells accumulate at the outer strip of medulla,
in the absence of a simultaneous increase in polymor-
phonuclear leukocytes, within 24 hours of injury [17, 22,
23]. A specific pathogenic role for CD4+ve T-cells has
been demonstrated by several experimental approaches.
The use of mice genetically lacking CD4+ve T-cell pop-
ulations, depletion of CD4+ve T-cells before induction
of ischemia, and administration of immunosuppressive
agents or costimulatory blockade are all associated with
attenuation of renal injury, even though innate immune
mechanisms remained intact [16, 21, 23–25, 37–41]. The
extension of our experiments to a unilateral renal artery
clip model in the mouse provides clear evidence that
acute ischemia of the kidney is also associated with abnor-
mal DC-mediated presentation of antigen to CD4+ve T-
cells in the RLNs. The finding that CD11c-depleted cells
from the RLN draining the ischemic kidney remained in-
capable of initiating antigen-specific CD4+ve T-cell pro-
liferation suggests that other MHC II–expressing APC
populations (macrophages, B-cells) do not participate in
early T-cell activation following IR. This increase in DC
antigen-presenting capacity occurred within 24 hours of
the ischemic episode and, while clearly most evident in
the lymph node draining the ischemic kidney, was also
observed within the contralateral RLN. The latter obser-
vation is consistent with an immunologic component to
the contralateral renal dysfunction reported by several
groups following experimental unilateral renal ischemia
[44, 45].
CONCLUSION
We suggest that our present findings are significant
from several perspectives. First, they provide, as best we
can tell from the present literature, the first evidence that
speaks directly to the involvement of DCs in relaying
information from the kidney injured by localized (renal
ischemia) or systemic (LPS) insults to the immune sys-
tem. Second, they provide the first evidence incriminat-
ing DCs as critical mediators of T-cell activation, which
is known to occur following renal ischemia. Third, they
provide a hitherto unrecognized mechanism (namely a
DC-dependent pathway) whereby a localized insult to the
kidney, such as that induced by regional ischemia, initi-
ates a systemic inflammatory process with adverse effects
on such vital organs as the heart and lungs. Fourth, they
provide a mechanism whereby injury inflicted on one kid-
ney evokes inflammatory responses in the contralateral
kidney. The results suggest that interventions targeting
DC antigen uptake, DC trafficking, or DC/T-cell interac-
tions merit further evaluation in the prevention or atten-
uation of acute renal failure of diverse causes.
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